Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. [electronic resource]
Producer: 20160404Description: 4167-75 p. digitalISSN:- 1527-7755
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Busulfan -- administration & dosage
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Graft vs Host Disease -- diagnosis
- Hematopoietic Stem Cell Transplantation
- Humans
- Immunosuppressive Agents -- administration & dosage
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Recurrence, Local -- diagnosis
- Prospective Studies
- Remission Induction
- Tacrolimus -- administration & dosage
- Transplantation Conditioning -- methods
- Transplantation, Homologous
- Treatment Outcome
- Unrelated Donors
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.